Benefit of Adjuvant Traditional Herbal Medicine With Chemotherapy for Resectable Gastric Cancer

Abstract

Introduction: Stomach cancer, historically, has a low survival rate advances in curative resection procedures. Objectives: To assess the potential benefits of traditional herbal medicines in conjunction with chemotherapy in postoperative gastric cancer patients in terms of overall survival and disease-free survival. Data Sources: We searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, a Chinese database (CNKI), a Korean database, a Japanese database, AMED, and CINAHL up to September 2016. We summarized survival data from all RCTs. Study Selection: All RCTs of oral traditional medicines for resectable gastric cancer compared with chemotherapy alone were eligible. Data Extraction: Thirteen eligible trials with survival data (1075 patients) were deemed eligible for inclusion. Results: There were 217 documented deaths of the 574 patients assigned to adjuvant traditional medicines groups and 319 documented deaths of the 501 patients assigned to the chemotherapy-only groups. Adjuvant traditional medicines were associated with a statistically significant benefit in terms of overall survival rate (hazard ratio = 0.56; 95% confidence interval = 0.47-0.66; P < .00001) and disease-free survival (hazard ratio = 0.54; 95% confidence interval = 0.43-0.66; P < .00001). Conclusion: Among the RCTs included, the inclusion of postoperative adjuvant traditional medicines was associated with reduced risk of death in gastric cancer patients, when survival rates were compared with the group of patients who received chemotherapy alone. However, most of the included studies utilized are thought to be of low quality, so it would certainly appear that more trials are both advisable and necessary to arrive at correct and convincing conclusions.

Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence

“…After demonstrating anticancer activity as monotherapy, natural compounds could further enhance their application by being chemotherapeutic adjuvants or cooperating drugs in combination therapy. Using TCM or traditional herbal medicine as a chemotherapeutic adjuvant in treating NSCLC or gastric cancer could improve the quality of life of patients, ameliorate myelosuppression, and possibly reduce mortality (Hou et al, ; Y. K. Lee, Bae, Yoo, & Cho, ; X. Wu et al, ). Further studies should look at herbal compounds or low MW compounds that can be applied as an alternative potent supplement for cancer therapy to attenuate any adverse effects and chemoresistance.…”

The Anticancer Effect of Huaier Extract in Renal Cancer 786-O Cells

“…There is accumulating evidence that natural herbal products play a potential role in the chemotherapy for cancer [11]. Huaier has been used in China for more than one thousand years.…”

A Network Pharmacological Approach to Reveal the Pharmacological Targets and Its Associated Biological Mechanisms of Prunetin-5-O-Glucoside against Gastric Cancer

“…The initial diagnosis, progression, and treatment of the disease condition is largely dismal [ 26 ]. Although chemotherapy and immunotherapy has very limited efficacy against the disease state, current emerging trends have turned toward the use of natural therapeutics in the developing research [ 27 ]. The advent of the big data era with the accumulation of evidence on the mechanisms of biological molecules as a progress of bioinformatic approaches provides a strong support in developing drugs through for network pharmacology [ 28 ].…”